Nikhil Lalwani
CEO, President at Ani Pharmaceuticals Inc (ANIP)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 16 NewSEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 5,400333,689 held (−2%) | $71.89 | $388K | +0.6% |
| Sep 16SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 5,400339,089 held (−2%) | $71.00 | $383K | +1.8% |
| Aug 26SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 5,400344,489 held (−2%) | $74.30 | $401K | -2.7% |
| May 13SEC | ANIPAni Pharmaceuticals Inc | Sell | 55,000349,889 held (−14%) | $77.57 | $4.3M | -6.8% |
- Sell
CEO, President Nikhil Lalwani sold $388K of ANIP at $71.89 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Nikhil Lalwani sold $383K of ANIP at $71.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Nikhil Lalwani sold $401K of ANIP at $74.30 — pre-scheduled 10b5-1 plan sale.